Neoadjuvant Therapy for Anaplastic Thyroid Carcinoma

Sagar Kansara; Maria E. Cabanillas; Mark Zafereo

doi:10.1007/978-3-030-73951-5_5

Neoadjuvant Therapy for Anaplastic Thyroid Carcinoma

Sagar Kansara, Maria E. Cabanillas, Mark Zafereo

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Anaplastic thyroid cancer (ATC) accounts for approximately 1–2% of all thyroid cancers in the United States, while the prevalence ranges from 1% to 10% worldwide (Smallridge RC and Copland JA. Clin Oncol (R Coll Radiol). 2010;22:486–97.). Though rare, ATC remains a deadly disease, accounting for over half of annual deaths from thyroid carcinoma. In this chapter, the treatments for anaplastic thyroid carcinoma and their clinical utility within the realm of neoadjuvant therapy will be explored.

Original language	English (US)
Title of host publication	Innovations in Modern Endocrine Surgery
Publisher	Springer International Publishing
Pages	81-88
Number of pages	8
ISBN (Electronic)	9783030739515
ISBN (Print)	9783030739508
DOIs	https://doi.org/10.1007/978-3-030-73951-5_5
State	Published - Jan 1 2021

Keywords

Anaplastic thyroid carcinoma
Neoadjuvant therapy

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-73951-5_5

Cite this

@inbook{178949f031ca44d391efd45481c5a688,

title = "Neoadjuvant Therapy for Anaplastic Thyroid Carcinoma",

abstract = "Anaplastic thyroid cancer (ATC) accounts for approximately 1–2% of all thyroid cancers in the United States, while the prevalence ranges from 1% to 10% worldwide (Smallridge RC and Copland JA. Clin Oncol (R Coll Radiol). 2010;22:486–97.). Though rare, ATC remains a deadly disease, accounting for over half of annual deaths from thyroid carcinoma. In this chapter, the treatments for anaplastic thyroid carcinoma and their clinical utility within the realm of neoadjuvant therapy will be explored.",

keywords = "Anaplastic thyroid carcinoma, Neoadjuvant therapy",

author = "Sagar Kansara and Cabanillas, {Maria E.} and Mark Zafereo",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-3-030-73951-5_5",

language = "English (US)",

isbn = "9783030739508",

pages = "81--88",

booktitle = "Innovations in Modern Endocrine Surgery",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Neoadjuvant Therapy for Anaplastic Thyroid Carcinoma

AU - Kansara, Sagar

AU - Cabanillas, Maria E.

AU - Zafereo, Mark

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Anaplastic thyroid cancer (ATC) accounts for approximately 1–2% of all thyroid cancers in the United States, while the prevalence ranges from 1% to 10% worldwide (Smallridge RC and Copland JA. Clin Oncol (R Coll Radiol). 2010;22:486–97.). Though rare, ATC remains a deadly disease, accounting for over half of annual deaths from thyroid carcinoma. In this chapter, the treatments for anaplastic thyroid carcinoma and their clinical utility within the realm of neoadjuvant therapy will be explored.

AB - Anaplastic thyroid cancer (ATC) accounts for approximately 1–2% of all thyroid cancers in the United States, while the prevalence ranges from 1% to 10% worldwide (Smallridge RC and Copland JA. Clin Oncol (R Coll Radiol). 2010;22:486–97.). Though rare, ATC remains a deadly disease, accounting for over half of annual deaths from thyroid carcinoma. In this chapter, the treatments for anaplastic thyroid carcinoma and their clinical utility within the realm of neoadjuvant therapy will be explored.

KW - Anaplastic thyroid carcinoma

KW - Neoadjuvant therapy

UR - http://www.scopus.com/inward/record.url?scp=85160779866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85160779866&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-73951-5_5

DO - 10.1007/978-3-030-73951-5_5

M3 - Chapter

AN - SCOPUS:85160779866

SN - 9783030739508

SP - 81

EP - 88

BT - Innovations in Modern Endocrine Surgery

PB - Springer International Publishing

ER -

Neoadjuvant Therapy for Anaplastic Thyroid Carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this